ZK 137316
Latest Information Update: 28 Aug 2002
At a glance
- Originator Bayer Schering Pharma
- Developer Bayer Schering Pharma; Nonindustrial source
- Class Antiprogestogens; Contraceptives; Hormones
- Mechanism of Action Progesterone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pregnancy
Most Recent Events
- 22 Feb 1999 New profile
- 22 Oct 1997 Preclinical development for Pregnancy (Prevention) in Germany (Unknown route)
- 22 Oct 1997 Preclinical development for Pregnancy (Prevention) in USA (Unknown route)